New study explores selenoproteins as clues in breast cancer

NCT ID NCT05817227

First seen Jan 05, 2026 · Last updated May 12, 2026 · Updated 25 times

Summary

This study is looking at proteins called selenoproteins in people with a type of breast cancer called triple-negative breast cancer (TNBC). Researchers want to see if these proteins can help predict how the disease will progress or be used as targets for future treatments. The study will involve 300 patients and 100 healthy volunteers, and will collect tissue and blood samples to measure selenoprotein levels. No new treatments are being tested; the goal is to gather information.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Istituto Nazionale Tumori - Fondazione "G.Pascale", IRCCS

    RECRUITING

    Naples, Napoli, 80131, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Istituto Nazionale Tumori Regina Elena

    RECRUITING

    Roma, Roma, 00144, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.